Press Release Details

View all news

Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference


SECAUCUS, N.J., Aug. 28, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York.  Stephen Rusckowski, Chairman, President and CEO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Monday, September 9, 2019 at 11:40 a.m. Eastern Time.

Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)

The presentation will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at  In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 9, 2019. 

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 46,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.

Cision View original content to download multimedia:

SOURCE Quest Diagnostics Incorporated

Shawn Bevec (Investors): 973-520-2900, Dennis Moynihan (Media): 973-520-2800

Categories: Press Releases
View all news